Unusual side effect from a luteinizing hormone-releasing hormone agonist, leuprorelin, in the treatment of prostate cancer: a case report

BACKGROUND: The treatment options for high-risk prostate cancer are either radical prostatectomy or radiotherapy/brachytherapy depending on the patients’ prognosis. In older men with multiple comorbidities, radiotherapy with androgen deprivation therapy is an attractive option. Common side effects o...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, John I-Chiang, Bucci, Joseph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5106809/
https://www.ncbi.nlm.nih.gov/pubmed/27836000
http://dx.doi.org/10.1186/s13256-016-1110-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5106809/
https://www.ncbi.nlm.nih.gov/pubmed/27836000
http://dx.doi.org/10.1186/s13256-016-1110-5

Ejemplares similares